The global Network Point-Of-Care Glucose Testing Market size is expected to reach USD 1.6 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 3.9% from 2021 to 2028. Some of the key players in this industry are F. Hoffmann-La Roche Ltd., Abbott, Nova Biomedical, Bayer AG/Ascensia Diabetes Care Holdings AG, Danaher. Increasing demand for safe and accurate remote patient monitoring options and the need for data-based treatment regimens are major factors driving the market. The integration of advanced technologies including Bluetooth Low Energy (BLE) and Infrared is expected to fuel the market growth in the upcoming years.
Expanding patient
base in Asia Pacific and the Middle East and the high demand for advanced
diabetes management systems are creating significant growth opportunities in
these regions. These regions also include some of the highly preferred
destinations for medical tourism. Increasing demand for world-class healthcare
services and rising adoption of advanced technology are some of the factors
boosting the market growth in these regions.
Network point-of-care glucose meters were extensively used in COVID-19 care. This enabled doctors to remotely observe glucose levels with minimal risk of infection. In addition, a large amount of data is still being used to customize treatment plans for diabetic COVID-19 patients. Preference for telemedicine and trends of home healthcare settings for chronic patients are some of the factors expected to expand the applications of network-based point-of-care devices.
Related Press
Release@ Network
Point-of-Care Glucose Testing Market Report
Network Point-of-Care Glucose Testing Market Report Highlights
- Network
point-of-care devices were in high demand during the first and second wave
of COVID-19 owing to their advantage of remote patient monitoring
- Based on product,
the Accu-Chek Inform II segment held the largest revenue share in 2020 and
is expected to expand at a lucrative growth rate during the forecast
period
- North America
held the largest revenue share in 2020 and is predicted to maintain its
lead over the forecast period owing to the factors such as the presence of
major players and high adoption rate
About Us:
Grand View Research, Inc. is a U.S. based market research
and consulting company, registered in the State of California and headquartered
in San Francisco. The company provides syndicated research reports, customized
research reports, and consulting services. To help clients make informed
business decisions, the company offers market intelligence studies ensuring
relevant and fact-based research across a range of industries including
technology, chemicals, materials, healthcare and energy.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com
No comments:
Post a Comment